Tower Research Capital LLC (Trc) Cyclerion Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.43 - $0.9 $1,409 - $2,951	-3,279 Reduced 19.81%	13,273 $6,000
Q4 2022 Feb 10, 2023	BUY	$0.42 - $18.8 $3,153 - $141,169	7,509 Added 83.04%	16,552 $11,000
Q3 2022 Nov 10, 2022	SELL	$0.58 - $18.2 $2,625 - $82,373	-4,526 Reduced 33.36%	9,043 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.47 - $1.29 $1,828 - $5,019	-3,891 Reduced 22.29%	13,569 $8,000
Q1 2022 May 12, 2022	SELL	$0.96 - $1.78 $5,075 - $9,410	-5,287 Reduced 23.24%	17,460 $19,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $9,345 - $17,913	-5,991 Reduced 20.85%	22,747 $39,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $78,454 - $118,687	28,738 New	28,738 $88,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.29 $14,586 - $28,704	-6,691 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $3,405 - $6,481	1,266 Added 23.34%	6,691 $19,000
Q4 2020 Feb 16, 2021	SELL	$2.25 - $7.12 $42,693 - $135,102	-18,975 Reduced 77.77%	5,425 $17,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $66,497 - $161,247	19,219 Added 370.95%	24,400 $148,000
Q2 2020 Aug 13, 2020	BUY	$2.37 - $7.14 $5,337 - $16,079	2,252 Added 76.89%	5,181 $31,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $7,205 - $17,105	2,929 New	2,929 $8,000
Q4 2019 Feb 07, 2020	SELL	$1.8 - $13.43 $6,809 - $50,805	-3,783 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$8.12 - $14.54 $11,018 - $19,730	1,357 Added 55.94%	3,783 $46,000
Q2 2019 Aug 13, 2019	BUY	$9.6 - $22.85 $23,289 - $55,434	2,426 New	2,426 $28,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.